Virulence factors are the weapon systems that bacteria use to establish infection, damage host tissue, evade the immune system, and tolerate antibiotics. Targeting virulence factors disarms bacteria, having a disease-modifying effect on pathogenicity that supports immune clearance.
Swarming is a population-level motility that is a key driver of acute virulence, as swarming populations increase their expression of virulence factors and have greater antibiotic resistance1.
Our novel small molecule targets a phosphodiesterase (PDE) regulating c-di-GMP signalling in P. aeruginosa and other Gram-negative bacteria. C-di-GMP is a bacterial-specific second messenger controlling virulence, motility, and antibiotic tolerance2. VEI-001 prevents swarming and suppresses multiple key virulence factors.
This “upstream blocker” approach has synergy with antibiotics, potentiating their activity and preventing resistance. This is a key differentiator between VEI-001 and other virulence factor therapies, which target downstream effectors.
Virulence Factor Targeting
References:
Overhage J, Bains M, Brazas MD, Hancock RE. Swarming of Pseudomonas aeruginosa is a complex adaptation leading to increased production of virulence factors and antibiotic resistance. J Bacteriol. 2008
Jenal, U., Reinders, A. & Lori, C. Cyclic di-GMP: second messenger extraordinaire. Nat Rev Microbiol